No evidence of somatic FGFR3 mutation in various types of carcinoma - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Oncogene Année : 2001

No evidence of somatic FGFR3 mutation in various types of carcinoma

Mehdi Karoui
  • Fonction : Auteur
  • PersonId : 971452
Hélène Hofmann-Radvanyi
  • Fonction : Auteur
Claude Degott
  • Fonction : Auteur
Laetitia Faridoni-Laurens
  • Fonction : Auteur
Christophe Trésallet
  • Fonction : Auteur
  • PersonId : 984266
Christophe Penna
  • Fonction : Auteur
Catherine Boileau
Bernard Nordlinger
  • Fonction : Auteur

Résumé

Germline specific point mutations in the gene encoding fibroblast growth factor receptor 3 (FGFR3) are associated with autosomal dominant human skeletal dysplasia and craniosynostosis syndromes. Mutations identical to the germinal activating mutations found in severe skeletal dysplasias have been identified in certain types of cancer: at low frequency in multiple myeloma and cervix carcinoma and at high frequency in bladder carcinoma. We analysed, by SSCP and sequencing, the prevalence of FGFR3 mutations in 116 primary tumours of various types (upper aerodigestive tract, oesophagus, stomach, lung and skin). The regions analysed encompassed all FGFR3 point mutations previously described in severe skeletal dysplasia and cancers. No mutations were detected in the tumour types examined, suggesting that FGFR3 mutations are restricted to a few tumour types, the evidence to date suggesting that they are very specific to bladder carcinomas.

Dates et versions

hal-02345615 , version 1 (04-11-2019)

Identifiants

Citer

Mehdi Karoui, Hélène Hofmann-Radvanyi, Ute Zimmermann, Anne Couvelard, Claude Degott, et al.. No evidence of somatic FGFR3 mutation in various types of carcinoma. Oncogene, 2001, 20 (36), pp.5059-5061. ⟨10.1038/sj.onc.1204651⟩. ⟨hal-02345615⟩
227 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More